Loss of key protein contributes to neuron loss in ALS
March 5th, 2011 - 5:27 pm ICT by ANILondon, March 05 (ANI): Scientists have described the profound and pervasive role of a key protein in Amyotrophic lateral sclerosis pathology called TDP-43.
Amyotrophic lateral sclerosis, known as ALS or more popularly, Lou Gehrig’s disease, is a notorious neurodegenerative condition characterized by the progressive deterioration of brain and spinal cord neurons, resulting in the gradual but catastrophic loss of muscle control and ultimately, death.
A team of scientists at the University of California, San Diego School of Medicine and colleagues carried out the study.
In normal cells, TDP-43 is found in the nucleus where it helps maintain proper levels of ribonucleic acid (RNA), intermediate molecules that translate genetic information from DNA to proteins - the building blocks of cells.
In the majority of ALS patients, however, TDP-43 accumulates in the cell’s cytoplasm - the liquid that separates the nucleus from the outer membrane, and thus is excluded from the nucleus, which prevents it from performing its normal duties.
Using a mouse model, the researchers made three new important findings:
First, employing a comprehensive genome-wide RNA-binding mapping strategy, they discovered that more than one-third of the genes in the mouse brain are direct targets of TDP-43. In other words, the roles and functions of these genes are impacted by the presence - or absence - of normal TDP-43.
Second, the genes most affected had numerous TDP-43 binding sites on very long introns. Introns are the non-coding portions of a gene that are not used to make proteins. Typically, introns are removed (spliced out) during the development of mature messenger RNA. Introns, however, contain binding sites for RNA binding proteins such as TDP-43, to regulate the splicing process.
“This is an important finding as genes expressed in the central nervous system have much longer introns than genes expressed in any other tissues,” said Gene Yeo, assistant professor in the Department of Cellular and Molecular Medicine.
“This may explain the neuronal selectivity of the disease, and why other types of cells aren’t affected.”
Third, TDP-43 affects the alternative splicing of many genes. In fact, it affects the alternative splicing of its own RNA message.
Said Yeo: “This autoregulation keeps TDP-43 protein levels in check. The loss of TDP-43 removes this check; more TDP-43 is generated and more is likely to accumulate in the cytoplasm.”
The deep and expansive impact of misaggregated TDP-43 and the concurrent loss of normal TDP-43 appear to extend beyond ALS. The protein is a central component in the pathogenesis of an ever-increasing list of neurodegenerative conditions. For example, accumulating abnormal TDP-43 in neuronal cytoplasm has been documented in frontotemporal lobar dementia, a neurological disorder that results in progressive changes in personality, the ability to concentrate, social skills, motivation and reasoning.
“It is likely that TDP-43 affects many other neurodegenerative diseases,” said Yeo.
The study has been published in the advance online edition of the journal Nature Neuroscience. (ANI)
- Effects of genetic defect in myotonic muscular dystrophy revealed - Jan 25, 2010
- New technique to visualize gene expression in mammalian cells found - Jan 17, 2011
- ALS causing gene discovered - Dec 10, 2010
- Potential therapeutic target for Parkinson's, Alzheimer's identified - Mar 12, 2011
- Proteins linked with Alzheimer's clump in normal aging - Aug 11, 2010
- Protein that shuttles RNA into mitochrondria discovered - Aug 08, 2010
- How misfolded protein spreads from cell to cell, potentially spreading disease - Feb 19, 2011
- Central switch that controls cell movements discovered - Dec 08, 2010
- Novel gene therapy shows promise against Alzheimer's - Mar 05, 2011
- 'Survival protein' can help treat neuro-disorders - May 24, 2011
- Scientists find eye development error causing cataracts, glaucoma - Mar 25, 2011
- New genetic risk factor for Lou Gehrig's disease identified - Aug 26, 2010
- Gene therapy to brain may treat major depression - Oct 21, 2010
- Retrovirus could be responsible for Lou Gherig's disease: Study - Mar 03, 2011
- New research promises treatment for swallowing disorders - Apr 29, 2010
Tags: amyotrophic lateral sclerosis, assistant prof, california san diego, catastrophic loss, central nervous system, genetic information, london march, lou gehrig, mapping strategy, messenger rna, mouse brain, mouse model, muscle control, outer membrane, pervasive role, progressive deterioration, ribonucleic acid, rna binding proteins, tdp, university of california san diego